Two studies presented at ASCO's annual meeting used ctDNA testing to determine which patient might benefit from anti-EGFR retreatment.

Copyright: © 2004 Elsevier Ltd. Published by Elsevier Ltd. Pancreatic cancer is one of the commonest causes of death from cancer. Despite therapy with surgery ...

FIRE-4 (AIO KRK-0114): Randomized study evaluating the efficacy of cetuximab re-challenge in patients with metastatic RAS wild-type colorectal cancer responding to first-line treatment with FOLFIRI ...

Institute of Human Genetics, Molecular Developmental Genetics, University Medical Center Göttingen, Göttingen, Germany Hedgehog signaling plays pivotal roles in embryonic development, adult ...

1 Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 2 Key Laboratory of Organ Transplantation, Ministry of ...